Find practical information about diabetes treatment and management, including blood sugar monitoring, medications, lifestyle changes, complications and everyday diabetes care.
German researchers find that both stable glucose levels and greater daily fluctuations may influence the next day’s wellbeing in those with diabetes, challenging conventional control strategies. A German research team has found that blood sugar patterns may affect how people…
Revvity has introduced a CE-IVDR-certified automated blood test designed to identify children at risk of type 1 diabetes long before clinical symptoms appear, marking a significant step towards earlier diagnosis and intervention. Revvity has launched a new automated blood test…
Clywedog Therapeutics’ innovative oral diabetes medication, balomenib, shows promising long-lasting effects in adults with type 2 diabetes, paving the way for a potential new disease-modifying treatment. Clywedog Therapeutics says its experimental oral diabetes medicine balomenib produced benefits that persisted after…
As US lawsuits mount over possible associations between GLP-1 medicines like Ozempic and rare eye conditions, experts urge caution amid incomplete scientific evidence and expanding clinical warnings. Concerns over a possible link between widely used GLP-1 medicines and sudden vision…
GlucoTrack, still navigating development hurdles, has announced a fresh $3.1 million public offering amid continued reliance on external funding to bring its innovative implantable glucose monitor to market. GlucoTrack has moved to raise fresh capital just days after outlining a…
As children return to school, experts highlight the importance of personalised plans and staff training to ensure safe and inclusive diabetes care, addressing persistent gaps in support and communication. For families of children with type 1 diabetes, the start of…
A pioneering study from Lusaka, Zambia, uncovers how metabolic and clinical factors interplay to influence early vascular complications in type 2 diabetes, highlighting urgent diagnostic and treatment challenges in low- and middle-income countries. Type 2 diabetes is placing a growing…
New insights reveal that diabetic kidney damage often develops without symptoms, stressing the importance of regular tests to prevent advanced disease in high-risk groups, especially in India and the US. Diabetes can damage far more than blood sugar levels, and…
A pioneering Japanese study aims to determine whether the widely used diabetes medication tofogliflozin impacts muscle mass in lean seniors, addressing concerns about potential muscle loss linked to SGLT2 inhibitor treatment in older patients without obesity. Japanese researchers have launched…
Argentina’s medicines regulator has authorised a 7.2 mg weekly dose of semaglutide, expanding options for personalised obesity management amid promising trial results and ongoing safety assessment. Argentina’s medicines regulator has approved a higher weekly dose of semaglutide for adults with…
New research from UCLA Health suggests that GLP-1 receptor agonists, commonly used for type 2 diabetes and obesity, may lower the risk of serious fractures in older adults, challenging concerns about their impact on bone health. New research from UCLA…
In a significant breakthrough, Novo Nordisk’s experimental drug CagriSema has demonstrated superior weight loss results compared to tirzepatide in late-stage trials, signalling a potential shift in the competitive landscape of metabolic disease treatments. Novo Nordisk said on Monday that its…
